BRIEF published on 05/20/2024 at 13:14, 1 year 9 months ago Edison publie une mise à jour sur Target Healthcare REIT : le troisième trimestre montre une dynamique positive continue Dividendes FPI FPI De Soins De Santé Cible Mise À Jour Du Troisième Trimestre Valeurs Des Propriétés
BRIEF published on 05/20/2024 at 13:05, 1 year 9 months ago Aclara Appoints Dr. Kurt Forrester as Lead Advisor to Its Heavy Rare Earths Separation Project Rare Earths Sustainable Energy Aclara Resources Vertical Integration Dr. Kurt Forrester
BRIEF published on 05/20/2024 at 13:05, 1 year 9 months ago Aclara nomme le Dr Kurt Forrester au poste de conseiller principal pour son projet de séparation des terres rares lourdes Terres Rares Ressources D'Aclara L'énergie Durable Intégration Verticale Dr Kurt Forrester
BRIEF published on 05/20/2024 at 13:05, 1 year 9 months ago Lahontan Gold Corp Mobilizes Drill Rig to Santa Fe Mine Project Mineral Resource Estimate Preliminary Economic Assessment Lahontan Gold Corp Santa Fe Mine Drill Rig
BRIEF published on 05/20/2024 at 13:05, 1 year 9 months ago Lahontan Gold Corp mobilise une plate-forme de forage pour le projet minier de Santa Fe Estimation Des Ressources Minérales Evaluation Économique Préliminaire Lahontan Gold Corp. Mine De Santa Fé Appareil De Forage
BRIEF published on 05/20/2024 at 12:58, 1 year 9 months ago Edison Issues Review on BB Biotech (BION): A Recovering Sector with a Healthy Prognosis Investment Dividend Biotech Sector Market Outlook BB Biotech
BRIEF published on 05/20/2024 at 12:58, 1 year 9 months ago Edison publie une revue sur BB Biotech (BION) : un secteur en reprise avec un pronostic sain Investissement Dividende Perspectives Du Marché BB Biotechnologie Secteur Biotechnologique
BRIEF published on 05/20/2024 at 12:35, 1 year 9 months ago NV-387 Shows Promising Results in Treating Lethal RSV Infection in Animal Study NanoViricides NV-387 Clinical Trials Antiviral RSV
BRIEF published on 05/20/2024 at 12:35, 1 year 9 months ago Le NV-387 montre des résultats prometteurs dans le traitement de l'infection mortelle par le VRS dans une étude animale NanoViricides NV-387 Essais Cliniques Antiviral VRS
BRIEF published on 05/20/2024 at 10:56, 1 year 9 months ago Novacyt annonce la publication de ses résultats financiers et convoque son Assemblée Générale Annuelle Résultats Financiers Assemblée Générale Webinaire Investisseurs Novacyt
Published on 03/10/2026 at 14:00, 3 hours 10 minutes ago Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
Published on 03/10/2026 at 14:00, 3 hours 10 minutes ago Vox Royalty to Participate in the 38th Annual Roth Conference
Published on 03/10/2026 at 13:40, 3 hours 30 minutes ago Nextech3D.ai Reports Strong Start to 2026 With 50 New Customer Contracts Worth $230K, Driving Accelerating Adoption of Its AI Event Technology Platform
Published on 03/10/2026 at 13:30, 3 hours 40 minutes ago Solitario Files Drilling Plan of Operations for Its Bright Angel Gold - Copper Project
Published on 03/10/2026 at 13:00, 4 hours 10 minutes ago Datametrex Integrates AI to Healthcare To Enhance Efficiencies
Published on 03/10/2026 at 15:30, 1 hour 40 minutes ago Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease
Published on 03/10/2026 at 14:45, 2 hours 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Published on 03/10/2026 at 14:45, 2 hours 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 03/10/2026 at 14:44, 2 hours 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/10/2026 at 14:43, 2 hours 26 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 03/09/2026 at 18:43, 22 hours 27 minutes ago Reporting on share buyback transactions carried out between March 2 and March 6, 2026
Published on 03/09/2026 at 18:43, 22 hours 27 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 2 au 6 mars 2026
Published on 03/09/2026 at 18:21, 22 hours 48 minutes ago TERACT - EN REPONSE A L’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS ET LES BSAR B DE LA SOCIÉTÉ TERACT
Published on 03/09/2026 at 18:00, 23 hours 10 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 03/09/2026 at 18:00, 23 hours 10 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
